Form 4: Mission Produce Director Luis Gonzalez Sells Shares

Sentiment:

SEC Form 4 Filing


Director Luis Gonzalez of Mission Produce, Inc. sold 6,869 shares of common stock at an average price of $12.01 on March 28, 2024.

Summary

  • On March 28, 2024, Luis Gonzalez, a director and 10% owner of Mission Produce, Inc., sold 6,869 shares of common stock at an average price of $12.01.
  • The sale was executed at prices ranging from $12.00 to $12.02.
  • Following the transaction, Gonzalez indirectly owns 7,767,038 shares through Beldar Enterprises, 365,000 shares through CORP SA 1, 345,000 shares through CORP SA 2, 365,000 shares through CORP SA 3, and 135,000 shares through CORP SA 4.
  • He also directly owns 26,696 shares.
  • Rosario Del Pilar Vallejos Hinojosa shares power to vote and dispose the shares held by Beldar Enterprises and has full pecuniary interest in those shares.
  • Luis Gonzalez does not have any direct pecuniary interest in these shares.
  • Luis A. Gonzalez and Rosario Del Pilar Vallejos Hinojosa indirectly share the power to vote and dispose of the shares held by each of Corp SA 1, Corp SA 2, Corp SA 3, and Corp SA 4, and have shared pecuniary interest in these shares during their lifetimes.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a share sale by a company director. There's no indication of positive or negative implications for the company's performance.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for directors and officers to buy and sell shares of their company's stock. The impact on the stock price is usually minimal unless the transaction is very large or part of a broader trend.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies and their insiders.
  • The size of this transaction (6,869 shares) is relatively small compared to the total outstanding shares of Mission Produce, Inc.

Stakeholder Impact

  • The sale of shares by a director could have a minor psychological impact on shareholders, but the size of the transaction is unlikely to cause significant concern.

Key Dates

DateDescription
03/28/2024Date of the transaction: sale of 6,869 shares of common stock.
04/01/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.